Treating Reproductive-Aged Women With Glucagon-Like Peptide-1 Receptor Agonists: What Are the Clinical Considerations?

被引：0
作者：
Sharma, Garima [1 ]
机构：
[1] Inova Hlth Syst, Inova Schar Heart & Vasc, 8081 Innovat Pk Dr,7th Fl,700, Fairfax, VA 22031 USA
来源：
CIRCULATION | 2024年 / 150卷 / 19期
关键词：
cardiovascular-kidney-metabolic; GLP-RA; obesity; pregnancy;
D O I：
10.1161/CIRCULATIONAHA.124.070766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1487 / 1489
页数：3
相关论文
共 50 条
  • [21] The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease
    Tsiampali, Chara
    Papaioannidou, Paraskevi
    Goulas, Antonis
    Polyzos, Stergios A.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (11) : 1063 - 1072
  • [22] Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal?
    Lau, Darren
    Gamble, John-Michael
    DIABETES OBESITY & METABOLISM, 2024, 26 (04) : 1150 - 1156
  • [23] Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus A Role in Cardiovascular Disease
    Smilowitz, Nathaniel R.
    Donnino, Robert
    Schwartzbard, Arthur
    CIRCULATION, 2014, 129 (22) : 2305 - 2312
  • [24] Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
    Resnick, Ortal
    Bril, Fernando
    Beauchamp, Giovanna
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [25] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome
    Tzotzas, Themistoklis
    Karras, Spyridon N.
    Katsiki, Niki
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (03) : 218 - 229
  • [26] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases
    Vilarrasa, E.
    Nicolau, J.
    de la Cueva, P.
    Goday, A.
    Gallardo, F.
    Martorell-Calatayud, A.
    Carrascosa, J. M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (01): : T56 - T65
  • [27] Pulse of Progress: A Systematic Review of Glucagon-Like Peptide-1 Receptor Agonists in Cardiovascular Health
    Sabina, Michael
    Alsamman, M. Mrhaf
    CARDIOLOGY RESEARCH, 2024, 15 (01) : 1 - 11
  • [28] An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning
    Rameshrad, Maryam
    Razavi, Bibi Marjan
    Lalau, Jean-Daniel
    De Broe, Marc E.
    Hosseinzadeh, Hossein
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (05) : 556 - 568
  • [29] Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease
    Clarke, Lindsay
    Passam, Ravi Teja
    Falahee, Bryn
    Jirapinyo, Pichamol
    Allegretti, Jessica R.
    Kelly, Colleen R.
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [30] Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe?
    Belancic, Andrej
    Kresovic, Andrea
    Troskot Dijan, Marija
    CLINICAL OBESITY, 2021, 11 (02)
12345